Am J Hematol
-
Publication Venue For
- Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.. 94:741-750. 2019
- Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors.. 94:563-574. 2019
- A multi-institutional comparison of younger and older adults with sickle cell disease.. 94:E115-E117. 2019
- Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.. 94:446-454. 2019
- Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting.. 94:223-230. 2019
- Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial.. 94:21-28. 2019
- Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease.. 93:1451-1460. 2018
- The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease.. 93:E391-E395. 2018
- A common functional PIEZO1 deletion allele associates with red blood cell density in sickle cell disease patients.. 93:E362-E365. 2018
- Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.. 93:1394-1401. 2018
- A case series describing causes of death in pregnant women with sickle cell disease in a low-resource setting.. 93:E167-E170. 2018
- Physician decision making in selection of second-line treatments in immune thrombocytopenia in children.. 93:882-888. 2018
- A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).. 93:159-168. 2018
- Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.. 93:E49-E52. 2018
- Implementation of multidisciplinary care reduces maternal mortality in women with sickle cell disease living in low-resource setting.. 92:872-878. 2017
- Recognition of early mortality in multiple myeloma by a prediction matrix.. 92:915-923. 2017
- Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry.. 92:929-939. 2017
- Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia.. 92:730-738. 2017
- Thrombospondin-1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia.. 92:E31-E34. 2017
- Patent foramen ovale in adults with sickle cell disease and stroke.. 91:E358-E360. 2016
- "Hairy" cells in acute promyelocytic leukemia: Excess myeloperoxidase with formation of needle-shaped crystalline projections on the cytochemical stain in a case with variant morphology.. 91:747-748. 2016
- Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study.. 91:687-691. 2016
- Secondhand smoke is associated with more frequent hospitalizations in children with sickle cell disease.. 91:313-317. 2016
- Effects of hydroxyurea treatment for patients with hemoglobin SC disease.. 91:238-242. 2016
- Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials.. 91:199-204. 2016
- A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy.. 90:796-799. 2015
- Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma.. 90:E111-E116. 2015
- Evidence gaps in the management of sickle cell disease: A summary of needed research.. 90:273-275. 2015
- Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry.. 90:187-192. 2015
- Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: importance of achieving treatment-free remission.. 90:242-249. 2015
- Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.. 90:139-143. 2015
- Silent cerebral infarction, income, and grade retention among students with sickle cell anemia.. 89:E188-E192. 2014
- Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia.. 89:721-725. 2014
- Factors associated with survival in a contemporary adult sickle cell disease cohort.. 89:530-535. 2014
- Parent education and biologic factors influence on cognition in sickle cell anemia.. 89:162-167. 2014
- Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.. 88:932-938. 2013
- Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease.. 88:179-184. 2013
- Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data.. 87:984-987. 2012
- Pathological bone fractures in a 20-year old athletic male with multifocal solitary plasmacytoma of bone.. 87:626-627. 2012
- Antiphospholipid syndrome: laboratory testing and diagnostic strategies.. 87 Suppl 1:S75-S81. 2012
- Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors.. 87 Suppl 1:S141-S145. 2012
- Postpartum hemorrhage: when uterotonics and sutures fail.. 87 Suppl 1:S16-S22. 2012
- Complications of implantable venous access devices in patients with sickle cell disease.. 87:224-226. 2012
- Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.. 86:E70-E73. 2011
- Predictors of complete responses with denileukin diftitox in cutaneous T-cell lymphoma.. 86:627-630. 2011
- An unusual nodal marginal zone lymphoma with bright CD10 expression: a potential diagnostic pitfall.. 85:546-548. 2010
- Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study.. 85:467-471. 2010
- IgG-lambda plasma cell myeloma with cytoplasmic azurophilic inclusion bodies.. 85:516-517. 2010
- Informational needs assessment of non-Hodgkin lymphoma survivors and their physicians.. 85:528-532. 2010
- The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.. 85:403-408. 2010
- Prominent Dutcher body formation in a case of follicular lymphoma with BCL6 gene rearrangement and intact BCL2 gene.. 85:218-219. 2010
- Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease.. 85:36-40. 2010
- Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement.. 85:79-81. 2010
- Definitions of the phenotypic manifestations of sickle cell disease.. 85:6-13. 2010
- Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study.. 85:29-35. 2010
- Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures.. 84:703-709. 2009
- Langerhans cell histiocytosis following acute leukemia in an adult.. 84:693-694. 2009
- The excess burden of stroke in hospitalized adults with sickle cell disease.. 84:548-552. 2009
- Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.. 84:408-413. 2009
- Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines.. 84:366-370. 2009
- D-dimer for the diagnosis of venous thromboembolism in children.. 84:62-63. 2009